Skip to content

Glasgow MRI and Rotablation Study

MRI Before and After Coronary Angioplasty With Rotational Atherectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02857790
Acronym
GlaMoRouS
Enrollment
58
Registered
2016-08-05
Start date
2012-03-31
Completion date
2016-06-30
Last updated
2016-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Rotablation, High speed rotational atherectomy, Type IV myocardial infarction, Cardiac magnetic resonance imaging, CMR, Percutaneous Coronary Intervention

Brief summary

Percutaneous coronary intervention (PCI) with adjunctive high speed rotational atherectomy (HSRA) is commonly used to treat complex and calcified coronary artery stenoses. Theoretically, HSRA may have deleterious effects on the coronary microcirculation and result in peri-procedural myocardial infarction (Type 4a MI). This study is assessing the effects of HSRA PCI using serial multi-parametric stress perfusion cardiac magnetic resonance imaging (CMR) (1.5 Tesla MAGNETOM Avanto, Siemens Healthcare). The study will prospectively enrol up to 75 patients (minimum completed cohort of 50 patients) undergoing elective HSRA PCI and performing multi-parametric CMR at 3 time-points: before HSRA, 1 week post-HSRA, and 6 months post-HSRA. Myocardial perfusion will be assessed using pharmacological stress with intravenous adenosine (140 micrograms/kg/min) at each time point. High-sensitivity cardiac troponin (hsTn) and ECGs will be performed post-HSRA.

Detailed description

High Speed Rotational atherectomy (HSRA) is a technique used during angioplasty in the treatment of calcified coronary arteries. Rotablation debulks resistant calcium in the coronary artery plaque thus facilitating stent deployment and expansion. The atherectomy technique involves a rotating diamond-tipped burr which breaks down the calcium into small particles which are washed forward by the blood flow into the smaller coronary branches supplying the heart muscle. The dispersed calcium particles may block these smaller blood vessels, interrupting blood flow to an extent that may result in heart muscle damage. When this injury becomes detectable clinically, with symptoms, ECG changes and increased troponin, an iatrogenic type IV myocardial infarction (MI) is diagnosed. Cardiac magnetic resonance imaging (CMR) is the gold standard method for imaging the heart providing detailed information on cardiac function and muscle injury. This is a prospective cohort observational study of 60 patients undergoing coronary angioplasty with rotational atherectomy. The aim of the study is to investigate myocardial injury revealed by paired CMR scans before and after rotational atherectomy. The hypothesis is that following rotational atherectomy, displacement of calcified particles cause microvascular obstruction leading to reduced perfusion. Since myocardial perfusion and pump function are linked, as myocardial perfusion is reduced after atherectomy, so myocardial contractility (i.e. strain) will reduce. In a second analysis, computer modelling will be used to integrate the different types of CMR information to better understand the spatial, temporal and pathological evolution of myocardial infarction (www.softmech.org). The further hypothesis is that despite CMR detectable infarction the incidence of clinical type IV MI will be low. CMR scans will be performed 1 week before, 1 week and 6 months post rotablation. Cardiac troponin and ECGs will be performed post rotablation to determine the incidence of type IV MI.

Interventions

None listed

Sponsors

University of Glasgow
CollaboratorOTHER
Cardiovascular Research Foundation, New York
CollaboratorOTHER
Medical Research Scotland
CollaboratorUNKNOWN
Chief Scientist Office of the Scottish Government
CollaboratorOTHER_GOV
Scottish Funding Council
CollaboratorUNKNOWN
Engineering and Physical Sciences Research Council (EPSRC)
CollaboratorUNKNOWN
NHS National Waiting Times Centre Board
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stable angina * Indication for PCI with rotablation

Exclusion criteria

* Other major systemic illness * Contra-indication to CMR * Pregnancy * CKD (eGFR\<30) * Pre-existing infarct in culprit vessel territory on ECG, echo or baseline CMR * Chronic total occlusion

Design outcomes

Primary

MeasureTime frame
Change in circumferential myocardial strain1 week and 6 months post-rotablation

Secondary

MeasureTime frame
Incidence of type IV myocardial infarction6-12 hours post-rotablation
Change in ischaemic burden1 week and 6 months post-rotablation
Change in left ventricular ejection fraction (LVEF)1 week and 6 months post-rotablation
Incidence of CMR detected de novo late gadolinium enhancement1 week and 6 months post-rotablation
Index of Microcirculatory Resistance (IMR)Intra-procedural baseline, intra-procedural post-rotablation, and intra-procedural post-stenting
Minimum Stent Area (MSA)Intra-procedural post-rotablation
Change in left ventricular (LV) volumes1 week and 6 months post-rotablation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026